YMTX   $13.23  8.62% Market Closed

Yumanity Therapeutics Inc
Total Cash 11.85M
totalCashPerShare 1.091
EBITDA -32.91M
Total Debt 1.14M
quickRatio 1.571
currentRatio 1.927
Total Revenue 5.08M
debtToEquity 14.338
Revenue/Share 0.48
ROA -0.42986
ROE -1.57404
grossProfits -18.37M
freeCashflow -17.94M
operatingCashflow -30.13M
earningsGrowth
revenueGrowth -0.216
grossMargins -2.72208
ebitdaMargins 0.0
operatingMargins -6.5513096
profitMargins 0.0
enterpriseValue 7.75M
forwardPE
floatShares 8.70M
sharesOutstanding 10.86M
sharesShort 78.48K
sharesShortPriorMonth 61.74K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.26%
Short Ratio help_outline 2.16%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 3.15
Price To Book help_outline 0.60
earningsQuarterlyGrowth
netIncomeToCommon -38.59M
trailingEps -7.81%
forwardEps -4.56%
enterpriseToEbitda -0.23
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2022
institutionsCount 32
lastUpdated Feb. 15, 2023, 4:48 a.m.